Our Pricing

Understanding Sulphur Burps And Diarrhea From Mounjaro

Published on: June 03, 2026

Experiencing sulphur burps and diarrhea from Mounjaro is one of the most commonly reported gastrointestinal side effects during tirzepatide treatment. At Cured Pharmacy, our UK clinical team has supported thousands of patients through these temporary symptoms, which typically resolve as your body adjusts to the medication.

Why Mounjaro Causes Sulphur Burps and Diarrhea

Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist that fundamentally changes how your digestive system processes food [1]. By slowing gastric emptying—the rate at which your stomach releases food into the small intestine—tirzepatide creates a prolonged feeling of fullness that supports weight loss. However, this delayed gastric emptying means food remains in your stomach longer than usual, creating an environment where certain bacteria can produce hydrogen sulphide gas, the compound responsible for the characteristic rotten egg smell of sulphur burps.

In the SURPASS clinical trial programme, gastrointestinal side effects including nausea, diarrhea, and eructation (belching) were reported by 20-30% of participants during the dose escalation phase [1]. These symptoms were typically mild to moderate in severity and decreased significantly after the first 8-12 weeks of treatment. The mechanism behind diarrhea involves both the altered gut motility and changes in bile acid metabolism triggered by GLP-1 receptor activation [2].

The dual-action mechanism of tirzepatide—activating both GIP and GLP-1 receptors—may produce more pronounced gastrointestinal effects compared to single-pathway treatments like semaglutide, particularly during the initial titration period. Your UK prescriber will start you on the lowest maintenance dose (2.5mg weekly) specifically to minimise these adjustment symptoms whilst your digestive system adapts to the medication.

How Long Do Sulphur Burps and Diarrhea Last on Mounjaro?

Most patients find that sulphur burps and diarrhea from Mounjaro are temporary side effects that peak during the first 4-8 weeks of treatment, then gradually diminish as the body adjusts [1]. Clinical data from the SURPASS-3 trial showed that gastrointestinal adverse events were most frequent during dose escalation phases, with incidence rates dropping by approximately 60% after 12 weeks of stable dosing [1].

The timeline varies considerably between individuals. Some patients notice improvement within 2-3 weeks, whilst others may experience intermittent symptoms for up to three months. Symptoms often intensify temporarily when your dose is increased—Mounjaro follows a gradual escalation schedule, typically increasing every 4 weeks until reaching your target maintenance dose. Each dose increase may trigger a brief recurrence of digestive symptoms as your system recalibrates.

If sulphur burps or diarrhea persist beyond 12 weeks at a stable dose, or if symptoms are severe enough to affect your daily functioning, contact your prescriber. Persistent gastrointestinal symptoms may indicate the need for dose adjustment, additional supportive medications, or investigation of other contributing factors unrelated to tirzepatide.

When to Seek Medical Advice

Whilst mild digestive symptoms are expected with Mounjaro, certain warning signs require prompt medical attention. Contact your UK prescriber or GP immediately if you experience severe abdominal pain that doesn't resolve, bloody or black stools, signs of dehydration (dark urine, dizziness, reduced urination), persistent vomiting that prevents you keeping down fluids, or symptoms of pancreatitis including severe upper abdominal pain radiating to your back. These symptoms, though rare, require clinical evaluation to rule out serious complications.

Proven Strategies to Manage Sulphur Burps From Mounjaro

Dietary modification is your most effective tool for reducing sulphur burps whilst on tirzepatide treatment. Foods high in sulphur compounds—including cruciferous vegetables (broccoli, cauliflower, Brussels sprouts), alliums (onions, garlic, leeks), eggs, red meat, and certain dairy products—are the primary culprits. During the first 8-12 weeks of Mounjaro treatment, consider temporarily reducing your intake of these foods, then gradually reintroducing them as your tolerance improves.

Eating smaller, more frequent meals rather than three large meals daily works synergistically with Mounjaro's mechanism of action. Since tirzepatide already slows gastric emptying, overloading your stomach with large portions exacerbates delayed digestion and increases fermentation time. Aim for 5-6 smaller meals spread throughout the day, chewing thoroughly and eating slowly to reduce the amount of air you swallow—a significant contributor to burping.

Several over-the-counter remedies may provide symptomatic relief. Activated charcoal tablets (available without prescription) can absorb excess gas in the digestive tract, though they should be taken at least 2 hours away from Mounjaro and any other medications to avoid interference with absorption. Peppermint tea or enteric-coated peppermint oil capsules help relax the gastrointestinal smooth muscle and reduce gas production. Probiotics containing Lactobacillus and Bifidobacterium strains may help rebalance gut bacteria, though evidence for their effectiveness specifically with GLP-1 medications remains limited [3].

Foods to Prioritise and Avoid

Focus your diet on easily digestible proteins like white fish, chicken breast, and plant-based options such as tofu. Choose low-sulphur vegetables including courgette, cucumber, carrots, and leafy greens like spinach. Complex carbohydrates such as white rice, oats, and sweet potatoes are generally well-tolerated. Avoid carbonated beverages entirely during the adjustment phase, as they introduce additional gas into your system. Limit high-fat foods, which further delay gastric emptying and can worsen symptoms. Keep a food diary for the first month to identify your personal trigger foods—individual tolerance varies significantly.

Managing Diarrhea While Taking Mounjaro

Diarrhea management on Mounjaro requires a balance between symptomatic relief and allowing your body's natural adjustment process. Loperamide (Imodium), available over the counter at UK pharmacies, can be used for occasional symptom control, but shouldn't become a daily necessity. If you're reaching for anti-diarrheal medication more than twice weekly, discuss dose adjustment with your prescriber rather than masking ongoing symptoms.

Hydration is absolutely critical when experiencing diarrhea on tirzepatide. Aim for at least 2-2.5 litres of fluid daily, including oral rehydration solutions like Dioralyte if diarrhea is frequent. Dehydration can worsen other Mounjaro side effects including fatigue, dizziness, and nausea. Avoid caffeine and alcohol during symptomatic periods, as both have diuretic effects that compound fluid loss.

Soluble fibre supplements such as psyllium husk (Fybogel) can help normalise bowel movements by adding bulk to loose stools without causing constipation. Start with half the recommended dose and increase gradually. Conversely, temporarily reduce insoluble fibre from raw vegetables, whole grains, and seeds if diarrhea is persistent. The BRAT diet (bananas, rice, applesauce, toast) remains a sensible short-term approach during acute episodes, though it shouldn't be followed for more than a few days due to nutritional limitations.

Comparing Gastrointestinal Side Effects: Mounjaro vs Other Weight Loss Treatments

All GLP-1 receptor agonists share similar gastrointestinal side effect profiles, though the frequency and severity vary between medications [2]. Mounjaro's dual GIP/GLP-1 mechanism may produce slightly more pronounced digestive symptoms initially compared to single-pathway treatments like Wegovy (semaglutide) or Saxenda (liraglutide), particularly during dose escalation. However, clinical trial data suggests that once patients reach stable maintenance doses, the overall incidence of persistent gastrointestinal side effects is comparable across these medications.

Wegovy (semaglutide) was associated with nausea in approximately 20% of participants in the STEP trials, with diarrhea reported in 30% during the escalation phase [4]. These rates are similar to those observed with Mounjaro in the SURPASS programme. Saxenda, which requires daily rather than weekly injections, showed gastrointestinal side effects in 25-40% of patients, though the lower per-dose amount may result in a gentler adjustment curve for some individuals.

Non-injectable weight loss treatments like Orlistat work through an entirely different mechanism—blocking fat absorption in the intestine—and produce distinct gastrointestinal effects including oily stools and faecal urgency, particularly when dietary fat intake is high. These symptoms are directly related to the medication's mechanism and don't typically improve with time, unlike the temporary adjustment symptoms seen with GLP-1 treatments. Your UK prescriber will consider your individual tolerance, lifestyle, and medical history when recommending the most appropriate weight loss medication.

Switching Treatments Due to Side Effects

If gastrointestinal symptoms remain intolerable despite management strategies, switching to an alternative weight loss medication is a reasonable option. Some patients who struggle with Mounjaro's side effects tolerate Wegovy or Saxenda better, whilst others find that non-GLP-1 options like Orlistat suit their physiology more appropriately. Any treatment change requires clinical assessment by your UK prescriber, who will ensure safe transition protocols and appropriate washout periods where necessary. At Cured Pharmacy, our clinical team can reassess your suitability for alternative treatments through a follow-up consultation.

Getting Started With Mounjaro at Cured Pharmacy

Cured Pharmacy offers genuine UK-licensed Mounjaro (tirzepatide) KwikPen injections from £124.99, with transparent upfront pricing and no hidden fees. Every prescription requires a free online clinical assessment completed by our UK-registered prescribers, typically taking under 3 minutes. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees all clinical services, ensuring every patient receives appropriate prescribing decisions and ongoing support throughout their weight loss journey.

Your Mounjaro treatment includes comprehensive guidance on injection technique, dose escalation schedules, and side effect management strategies. We provide discreet packaging and flexible delivery options across the UK, with regular follow-up consultations to monitor your progress and adjust treatment as needed. All medications are sourced directly from licensed UK wholesalers and stored in our GPhC-registered pharmacy (9012511) under appropriate conditions.

Starting your consultation is straightforward—complete our online medical questionnaire, which asks about your weight loss history, current medications, and relevant medical conditions. A UK prescriber will review your assessment within hours, and if Mounjaro is clinically appropriate for you, we'll dispense your prescription and arrange delivery. If tirzepatide isn't suitable based on your individual circumstances, our prescriber will recommend alternative weight loss treatments from our range including Wegovy, Saxenda, or Orlistat, all available through the same streamlined process.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Nauck, M. A., Quast, D. R., Wefers, J., & Meier, J. J. (2021). GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art. Molecular Metabolism, 46, 101102. https://doi.org/10.1016/j.molmet.2020.101102 [accessed 13 August 2026]
3. Suez, J., Zmora, N., & Elinav, E. (2020). Probiotics in the next-generation sequencing era. Gut Microbes, 11(1), 77–93. https://doi.org/10.1080/19490976.2019.1586039 [accessed 13 August 2026]
4. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Mounjaro (tirzepatide) is a prescription-only medicine that must be prescribed by a qualified UK clinician after appropriate medical assessment.